Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany UpdateRegulatory14 Oct 2026

Indiabulls Ltd

With reference to your email bearing ref. no. L/SURV/ONL/PV/SJ/2026-27/4380 dated October 13, 2026, we wish to inform you that, as of now, there is no information / announcement, which is required to be disclosed by the Company in terms of SEBI (LODR) Regulations. For more details please refer attachment.

Indiabulls Ltd clarifies on price movement, stating there is no information/announcement required to be disclosed by the Company in terms of SEBI (LODR) Regulations.

Read more →📎 1 attachment
NSEPrice movementRegulatory14 Oct 2026

Indiabulls Limited

Price movement

Indiabulls Limited has submitted a response to the National Stock Exchange of India Limited regarding a significant movement in its price, stating that there is no information or announcement required to be disclosed by the company.

Read more →📎 1 attachment
NSEUpdatesRegulatory14 Oct 2026

Park Medi World Limited

Updates

Park Medi World Limited has informed the Exchange regarding a verification conducted by the Income Tax Department at some of its premises and subsidiaries, with no impact on operational performance.

Read more →📎 1 attachment
BSECompany UpdateRegulatory14 Oct 2026

Prime Focus Ltd

Intimation under Regulations 30 of the Securities and Exchange Board of India (Listing Regulations and Disclosure Requirements) Regulations, 2015 - Update on search and seizure proceedings by the Income Tax Department

Prime Focus Ltd has informed that the search and seizure proceedings by the Income Tax Department have concluded without any adverse findings, and the company's operations, financials, and activities remain unaffected.

Read more →📎 1 attachment
NSEGeneral UpdatesRegulatory14 Oct 2026

Prime Focus Limited

General Updates

Prime Focus Limited has informed that the search and seizure proceedings by the Income Tax Department have concluded without any adverse findings. The company has cooperated fully and maintained high standards of integrity and corporate governance.

Read more →📎 1 attachment
NSEGranting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals▲ PositiveRegulatory13 Oct 2026

ICICI Prudential Life Insurance Company Limited

Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals

ICICI Prudential Life Insurance Company Limited has received approval from the Insurance Regulatory and Development Authority of India for the appointment of Mr. Sidharatha Mishra as an Additional Director and further as the Managing Director & CEO for a period of five consecutive years.

Read more →📎 1 attachment
BSECompany Update▼ NegativeRegulatory13 Oct 2026

Reliance Power Ltd

Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

Reliance Power Ltd has disclosed receipt of an order of seizure from the Enforcement Directorate (ED) under Section 37A(1) of the Foreign Exchange Management Act (FEMA) for Rs. 2026.65 crore worth of shares in its wholly-owned subsidiary Sasan Power Limited and bank balances of Rs. 6.16 crore. The shares are already pledged to Power Finance Corporation Limited, a Government of India undertaking, and the company disputes the allegations of contravention of Section 4 of FEMA.

Read more →📎 1 attachment
NSEAction(s) initiated or orders passedRegulatory13 Oct 2026

Reliance Power Limited

Action(s) initiated or orders passed

Reliance Power Limited has informed the Exchange about an order of seizure of shares of its wholly-owned subsidiary Sasan Power Limited and bank balances by the Enforcement Directorate (ED) under Section 37A(1) of FEMA, related to foreign currency convertible bonds issued in 2006 and an overseas investment made in 2008.

Read more →📎 1 attachment
BSECompany UpdateRegulatory13 Oct 2026

Landmark Property Development Company Ltd

Compliance Certificate under regulation 74(5) for the period ended 30.09.2026

Landmark Property Development Company Ltd has filed a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026. The certificate confirms that securities received for dematerialisation were accepted or rejected by the depositories and that the security certificates received were mutilated and cancelled after due verification.

Read more →📎 1 attachment
NSEGeneral UpdatesRegulatory13 Oct 2026

Tribhovandas Bhimji Zaveri Limited

General Updates

Tribhovandas Bhimji Zaveri Limited has received approval from the Competition Commission of India for GRT Jewellers (India) Private Limited's proposed acquisition of a majority stake in the company.

Read more →📎 1 attachment
BSECompany UpdateRegulatory13 Oct 2026

Olympic Cards Ltd

Certificate under Regulations 74(5) of the SEBI(DP) Regulations, 2018 for the quarter ended 30th September, 2026. Based on the confirmation received from Cameo Corporate Services Limited, Registrar and Share Transfer Agent of the Company, we hereby certify that the securities received for dematerialization have been mutilated and cancelled after due verification and the name of the depository has been substituted in our records as the registered ....

Olympic Cards Ltd. has provided a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities for the quarter ended 30th September, 2026.

Read more →📎 1 attachment
NSEPress ReleaseRegulatory13 Oct 2026

Zydus Lifesciences Limited

Press Release

Zydus Lifesciences Limited has informed the Exchange that the USFDA inspection of its manufacturing plant at Moraiya, Ahmedabad, has concluded with 5 observations. The company will work with the USFDA to address these observations promptly.

Read more →📎 1 attachment
BSECompany UpdateRegulatory13 Oct 2026

Zydus Lifesciences Ltd

USFDA Inspection

Zydus Lifesciences Ltd has announced that the USFDA inspection of its manufacturing plant at Moraiya, Ahmedabad has concluded with 5 observations. The company will work closely with the USFDA to address these observations.

Read more →📎 1 attachment
← PreviousPage 107 of 600Next →